Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.

@article{Easton2003AmoxicillinclavulanicAA,
  title={Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.},
  author={J. L. Easton and Stuart Noble and Caroline M. Perry},
  journal={Drugs},
  year={2003},
  volume={63 3},
  pages={311-40}
}
UNLABELLED Amoxicillin/clavulanic acid (Augmentin), Augmentin ES-600 is a well established, orally administered combination of amoxicillin (a semisynthetic antibacterial agent) and clavulanic acid (a beta-lactamase inhibitor). Amoxicillin/clavulanic acid shows good activity against the main pathogens associated with acute otitis media (AOM), including penicillin-susceptible and -intermediate strains of Streptococcus pneumoniae, and beta-lactamase producing strains of Haemophilus influenzae and… CONTINUE READING
10 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…